Rani Therapeutics Holdings, Inc. (RANI)
Nasdaq: RANI · Pharmaceutical Preparations · San Jose, CA · filing with the SEC since 2021
Who owns Rani Therapeutics Holdings, Inc.
As filed with the SECHolders of 5% or more
5
Mir A Imran holds 22.1% of Class A Common Stock, par value $0.0001 per share, as its SCHEDULE 13D/A filed Oct 27, 2025 says.
Directors and officers
11
report now, of 18 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Mir A Imran
SCHEDULE 13D/A · filed Oct 27, 2025 · Class A Common Stock, par value $0.0001 per share
Raymond Debbane
SCHEDULE 13G · filed Oct 23, 2025 · Class A Common Stock, $0.0001 par value
RA Capital Management, L.P.
SCHEDULE 13G/A · filed Aug 14, 2026 · Class A Common Stock, $0.0001 par value per share · 9.9% in Oct 30, 2025
Srinivas Akkaraju
SCHEDULE 13D/A · filed May 28, 2026 · Class A Common Stock, $0.0001 par value per share · 9.9% in Oct 30, 2025
AWM Investment Company, Inc.
SCHEDULE 13G · filed Feb 13, 2026 · Class A Common Stock, Par Value $.0001
Armistice Capital, LLC
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Stock · reported falling below 5%, from 8.79% in Aug 14, 2025
South Cone Investments Limited Partnership
SCHEDULE 13D/A · filed Oct 22, 2025 · Class A Common Stock, par value $0.0001 per share · reported falling below 5%
Vanguard Capital Management
SCHEDULE 13G/A · filed Jul 31, 2026 · Common Stock · reported falling below 5%, from 5.12% in Apr 30, 2026
SymBiosis Capital Partners, LLC
SCHEDULE 13G/A · filed May 15, 2026 · Class A Common Stock · reported falling below 5%, from 6.5% in Feb 12, 2026
Orca Capital AG
SCHEDULE 13G/A · filed Jul 23, 2025 · Class A Common Stock, par value $0.0001 per share · reported falling below 5%, from 9.9% in Jul 17, 2025
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%, from 5.23% in Jan 30, 2026
What RANI reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Rani L L C
An entity · consolidated entity · owns, named in the 10-K filed Mar 26, 2026
1 subsidiary in 1 country, from the list filed with the 10-K filed Mar 26, 2026.
Insider tradesForm 4
1sales
3purchases
0sales on a scheduled plan
1people selling
$0sold, in dollars
$1.3Mbought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 24 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| South Cone Investments Limited Partnership | 10% owner | 2 | $15.7M | 0 | 0 | $0 |
| Imran Mir A | director | 0 | $0 | 0 | 2 | $1.3M |
| Imran Talat | Chief Executive Officer | 0 | $0 | 0 | 1 | $0 |
| Javadi Alireza | Chief Technical Officer | 1 | $0 | 0 | 0 | $0 |